LivaNova LIVN
NASDAQ LIVN
$78.96 -1.74 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT

LivaNova (LIVN) Income from Continuing Operations (2014 - 2026)

LivaNova's (LIVN) quarterly Income from Continuing Operations came in at $108.7 million in Q2 2026, up 300.03% year-over-year from $27.2 million in Q2 2025, and up 369.57% quarter-over-quarter from $23.1 million in Q1 2026.

Analysis

LivaNova (LIVN) Income from Continuing Operations (2014 - 2026) Analysis & Trends

LivaNova has disclosed Income from Continuing Operations across 13 years of filings, most recently posting $108.7 million for Q2 2026.

  • In Q2 2026, Income from Continuing Operations rose 300.03% year-over-year to $108.7 million; the TTM figure through Jun 2026 stood at $189.5 million (up 189.69% YoY), while the FY2025 annual figure was -$242.4 million, down 483.26% from the prior year.
  • Income from Continuing Operations came in at $108.7 million for Q2 2026 at LivaNova, up from $23.1 million in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of $108.7 million in Q2 2026 to a low of -$327.3 million in Q1 2025.
  • Average Income from Continuing Operations over 5 years is -$6.4 million, with a median of $16.4 million recorded in 2023.
  • Year-over-year, Income from Continuing Operations soared 1283.09% in 2024 and sank 680.83% in 2025.
  • Over 5 years, Income from Continuing Operations stood at $1.7 million in 2022, then surged by 867.81% to $16.4 million in 2023, then surged by 241.72% to $55.9 million in 2024, then tumbled by 44.69% to $30.9 million in 2025, then soared by 251.54% to $108.7 million in 2026.
  • Per Business Quant data, the three most recent Income from Continuing Operations figures were $108.7 million in Q2 2026, $23.1 million in Q1 2026, and $30.9 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 928.00 Mn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 823.20 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 1.48 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 1.28 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 905.00 Mn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 241.40 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -92.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 249.10 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 201.00 Mn
10 LivaNova 4.34 Bn 3.82 Bn 273.67 Mn 108.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 108.68 Mn
Mar 31, 2026 23.15 Mn
Dec 31, 2025 30.92 Mn
Sep 30, 2025 26.80 Mn
Jun 30, 2025 27.17 Mn
Mar 31, 2025 -327.30 Mn
Dec 31, 2024 55.89 Mn
Sep 30, 2024 32.92 Mn
Jun 30, 2024 16.36 Mn
Mar 31, 2024 -41.92 Mn
Dec 31, 2023 16.36 Mn
Sep 30, 2023 -7.29 Mn
Jun 30, 2023 1.18 Mn
Mar 31, 2023 7.40 Mn
Dec 31, 2022 1.69 Mn
Sep 30, 2022 -107.40 Mn
Jun 30, 2022 16.49 Mn
Mar 31, 2022 3.03 Mn
Dec 31, 2021 -5.09 Mn
Sep 30, 2021 -43.42 Mn